Global Health Limited announced the approval of a grant of 20,000 ESOPs to a single employee under its GHL LTIP 2024 Plan. This decision was made by the Nomination and Remuneration Committee on July 30, 2026. The stock options are exercisable at ₹1147 per share, with a vesting period of up to 5 years from the grant date. Each option corresponds to one equity share of ₹2 face value.
ESOP Grant Approved by Committee
In a regulatory filing dated July 30, 2026, Global Health Limited disclosed that its Nomination and Remuneration Committee has approved the grant of 20,000 Employee Stock Options (ESOPs). This grant is part of the company’s ‘GHL Employee Long Term Share Based Incentive Plan 2024’ (GHL LTIP 2024 Plan), specifically under Part –A, the GHL Employees Stock Option Scheme, 2024.
Key Details of the ESOP Grant
The current grant covers one employee and involves a total of 20,000 stock options. Each option provides the holder with the right to purchase one (1) equity share of the company at an exercise price of ₹1147. The face value of each equity share is ₹2.
Vesting and Exercise Period
The options granted are subject to specific vesting and exercise conditions outlined in the Grant letter. The vesting period for these options is subject to a maximum of 5 years from the date of the grant. Once vested, the options can be exercised within a maximum period of 3 years from the date of vesting of the last instalment of options under the GHL LTIP 2024 Plan. The committee meeting where this approval was granted commenced at 11:00 A.M. and concluded at 11:35 A.M. on the same day.
Source: BSE
